Quantcast

Latest epilepsy Stories

2014-07-16 20:23:07

LONDON, July 16, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Epilepsy Therapeutics in Asia Pacific Markets to 2019 - Treatment Options Enhanced As Novel Next Generation AEDs Show Improved Safety and Tolerability https://www.reportbuyer.com/product/2052296/Epilepsy-Therapeutics-in-Asia-Pacific-Markets-to-2019---Treatment-Options-Enhanced-As-Novel-Next-Generation-AEDs-Show-Improved-Safety-and-Tolerability.html Epilepsy Therapeutics in Asia Pacific...

2014-07-15 16:27:31

LONDON, July 15, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Epilepsy Therapeutics in Major Developed Markets to 2019 - New AEDs with Novel Mechanisms of Action Signal a Shift in Treatment Patternshttps://www.reportbuyer.com/product/2052297/Epilepsy-Therapeutics-in-Major-Developed-Markets-to-2019---New-AEDs-with-Novel-Mechanisms-of-Action-Signal-a-Shift-in-Treatment-Patterns.htmlEpilepsy Therapeutics in Major Developed Markets to 2019 - New AEDs with...

2014-07-15 08:28:37

WAYNE, Pa. and PORTO, Portugal, July 15, 2014 /PRNewswire/ -- BIAL, a research based international pharmaceutical company, and moksha8, a leading specialty pharmaceutical company in Latin America, announced today an exclusive license for the commercialization of eslicarbazepine acetate (Zebinix® / (Exalief®) in Brazil and Mexico for the treatment of epilepsy. Epilepsy is one of the most common neurological diseases, affecting 70 million worldwide and up to 5 million people in Latin America...

2014-07-14 08:27:51

Authorized Generic Topiramate Extended-Release Capsules Available Nationwide MAPLE GROVE, Minn., July 14, 2014 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. (Upsher-Smith), today announced the launch of Topiramate Extended-Release Capsules, the authorized generic of the recently Food and Drug Administration (FDA) approved Qudexy(TM) XR (topiramate) extended-release capsules, a once-daily, broad-spectrum antiepileptic drug specifically engineered to deliver a smooth pharmacokinetic (PK)...

2014-07-11 08:24:53

MISSISSAUGA, ON, July 11, 2014 /CNW/ - Sunovion Pharmaceuticals Canada Inc. (Sunovion) today announced that Health Canada approved APTIOM(TM) (eslicarbazepine acetate) for use as a once-daily adjunctive therapy for the treatment of partial-onset seizures in patients with epilepsy who are not satisfactorily controlled with conventional therapy. APTIOM(TM) is not indicated for use in patients under 18 years of age. Epilepsy is one of the most common neurological disorders and...

2014-07-11 08:24:35

Agreement with Biotie ends option for purchase and allows Neurelis to advance development of NRL-1 in preparation for NDA filing SAN DIEGO, July 11, 2014 /PRNewswire/ -- Neurelis, Inc. ("Neurelis") today announced an agreement with Biotie Therapies Corp. ("Biotie") to end the option held by Biotie to purchase Neurelis, clearing the way for Neurelis to commence further development of NRL-1 (intranasal diazepam) for pediatric and adult epilepsy patients who experience acute repetitive...

2014-07-09 23:10:43

Expanding market reach to Europe for its innovative software solution for automated brain atrophy measurements. San Diego, CA (PRWEB) July 09, 2014 CorTechs Labs, Inc. is pleased to announce that it has received CE Marking allowing the distribution in the European Economic Area (EEA) of their software product NeuroQuant, the leading volumetric brain imaging device. Already FDA Cleared and used by many reputable clinics and hospitals, NeuroQuant provides cutting-edge data analysis and...

2014-07-09 08:27:34

LOS ANGELES, July 9, 2014 /PRNewswire/ -- NeuroSigma, Inc. (NeuroSigma), a California-based life sciences company focused on commercialization of its non-invasive Monarch(TM) eTNS(TM) System for the treatment of neurological and neuropsychiatric disorders, today announced that the U.S. National Institutes of Health (NIH) has awarded UCLA a grant that funds a Phase II 90-subject pediatric clinical trial at the University of California, Los Angeles (UCLA) focused on the treatment of...

2014-07-08 08:29:45

European Clinical Data and Mechanism of Action Results Presented LOS ANGELES, July 8, 2014 /PRNewswire/ -- NeuroSigma, Inc. (NeuroSigma), a California-based life sciences company focused on commercialization of its non-invasive Monarch(TM) eTNS(TM) System for the treatment of neurological and neuropsychiatric disorders, today announced top-line summaries of presentations made last week at the 11th European Congress on Epileptology in Stockholm, Sweden, related to the use of external...

Scientists Discover On-Off Switch To A Person's Consciousness
2014-07-07 14:42:29

Alan McStravick for redOrbit.com - Your Universe online An orchestra, consisting of woodwinds, strings, percussion and brass instruments, each work off a score specific to the instrument they are playing. They each contribute a layer to the overall performance that, by themselves, would paint only a limited picture of what the piece was meant to sound like. Imagine Beethoven's 5th Symphony where all you heard were the oboes playing. The conductor, standing before the full written score, is...


Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.